📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Glyco-engineered anti-EGFR mAb elicits ADCC by NK cells from colorectal cancer patients irrespective of chemotherapy. (2014)

First Author: Oppenheim DE
Attributed to:  BRIC: Packaging cell lines for inherently manufacturable viral vectors funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/bjc.2014.35

PubMed Identifier: 24496456

Publication URI: http://europepmc.org/abstract/MED/24496456

Type: Journal Article/Review

Volume: 110

Parent Publication: British journal of cancer

Issue: 5

ISSN: 0007-0920